3-100637317-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032787.3(ADGRG7):āc.613A>Gā(p.Ile205Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,460,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032787.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRG7 | NM_032787.3 | c.613A>G | p.Ile205Val | missense_variant | 6/16 | ENST00000273352.8 | NP_116176.2 | |
ADGRG7 | XM_047449088.1 | c.208A>G | p.Ile70Val | missense_variant | 4/14 | XP_047305044.1 | ||
ADGRG7 | NM_001308362.1 | c.-25A>G | 5_prime_UTR_variant | 2/10 | NP_001295291.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRG7 | ENST00000273352.8 | c.613A>G | p.Ile205Val | missense_variant | 6/16 | 1 | NM_032787.3 | ENSP00000273352.3 | ||
ADGRG7 | ENST00000475887 | c.-25A>G | 5_prime_UTR_variant | 2/10 | 2 | ENSP00000419788.1 | ||||
ADGRG7 | ENST00000481361.1 | n.305A>G | non_coding_transcript_exon_variant | 2/4 | 4 | |||||
ADGRG7 | ENST00000493081.1 | n.303A>G | non_coding_transcript_exon_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1460942Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 726848
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at